Browsing by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
 

Showing results 45982 to 46001 of 207649 < previous   next >
WHF_1991_12(1)_p29-33.pdf.jpg
Drug information for patients in the community / D. Chavunduka ... [et al.]
Chavunduka, D; Dzimwasha, M; Madondo, F; Mafana, E; Mbewe, A; Nyazema, Norman Z ( 1991 )
EUR_ICP_QCPH_06_01_01.pdf.jpg
Drug information policies in countries of central and eastern Europe and the newly independent states : report on a WHO workshop, Hilleroed, Denmark, 27 March-2 April 1996
World Health Organization. Regional Office for Europe ( 1997 )
Abstract

The World Health Organization Regional office for Europe organized a workshop with countries of central and eastern Europe and the newly independent states (CCEE and NIS) to discuss and analyse the different aspects related to drug information, to review the existing situation of drug information and to promote the establishment and the further development of strategies and programmes aimed at providing clear, updated and unbiased drug information to professionals, as well as the patient. Drug regulators, drug policy makers and professionals participated. The workshop provided an overview and basic information on the issues and different strategies involved in drug information. It showed, in an international perspective, how governments can deal and actively intervene in this area to guarantee that the users are well informed. As a result of the workhop the participants have exchanged their views and experiences on the major issues in drug information in their countries. Practical and feasible recommendations on the provision and use of drug information were drawn up. Follow-up on the implementation of these recommendations at country and intercountry level will be done with the assistance of the Programme for Pharmaceuticals

Drug injecting and HIV infection : global dimensions and local responses / edited by Gerry V. Stimson, Don C. des Jarlais and Andrew L. Ball
Stimson, Gerald Vivian; Des Jarlais, Don C; Ball, Andrew; World Health Organization ( 1998 )
20_1_2006.pdf.jpg
Drug interaction between capecitabine and warfarin
( 2006 )
Drug labelling
( 1993 )
18_4_2004.pdf.jpg
Drug management
( 2004 )
19_4_2005.pdf.jpg
Drug management
( 2005 )
WHO_CONRAD_WP_2.1.pdf.jpg
Drug marketing
World Health Organization. Action Programme on Essential Drugs and Vaccines; Conference of Experts on the Rational Use of Drugs (1985 : Nairobi, Kenya) ( 1985 )
EB61_Conf.Paper-3_eng.pdf.jpg
Drug policies and management--essential drugs (draft resolution proposed by the rapporteurs)
Executive Board, 61 ( 1978 )
EB61R17_eng.pdf.jpg
Drug policies and management: essential drugs
Executive Board, 61 ( 1978 )
WHA31_12_eng.pdf.jpg
Drug policies and management: progress report by the Director-General
World Health Assembly, 31 ( 1978 )
E67886.pdf.jpg
Drug Polis : drug reimbursement pilot system, Kutaisi, Georgia : 1998 annual report
World Health Organization. Regional Office for Europe ( 1999 )
Abstract

Concerned with the high levels of patients' payments for drugs, the Ministry of Health of Georgia considered a drug reimbursement system 6 however few funds might be available for it 6 a useful instrument to improve affordability of drugs and access to primary health care services. During 199661997, a new drug reimbursement concept (Drug Polis) was developed by the WHO Special Project for Newly Independent States (NIS) in collaboration with the Georgian health authorities, and tested in Kutaisi since October 1997. This new concept is a voluntary insurance scheme, for which a fixed participation fee (the price of a booklet) is levied regardless of income. Benefits are: 20% reduction in the fee for visiting a doctor, 10% discount on prescription drugs below an accumulated annual expenditure of 100 Lari, and 50% reimbursement for all additional prescription drugs per year. After a slow start, 12 000 booklets were sold by the end of 1998. The pilot scheme shows that a comprehensive drug reimbursement system appeals to two thirds of the population. This system, where benefits increase with growing drug expenditure, can also be financially feasible and well managed in the Georgian setting. It is probably less viable as a voluntary independent scheme and might be better incorporated in a health insurance scheme or primary health care package. The public appreciated the fixed premium or fee per insured person, independent of income. This is useful knowledge for other areas of health insurance. It is recommended that Drug Polis should be continued in a wider regional setting, while other pilot sites, preferably in combination with health insurance funds or an integrated primary health care project, will eventually improve the affordability of drugs in Georgia and inspire other NIS

WHF_1996_17(4)_p386-388.pdf.jpg
Drug power to the people / P. H. Ehimwenma
Ehimwenma, P. H ( 1996 )
16_3_2010_0324_0328.pdf.jpg
Drug prescription habits in public and private health facilities in 2 provinces in South Africa
Mohlala, G.; Peltzer, K.; Phaswana Mafuya, N.; Ramlagan, S. ( 2010 )
Abstract

The aim of this study was to explore drug prescription habits using WHO standard indicators in 15 public hospitals and 36 private surgeries in 2 provinces in South Africa. A high mean number of drugs were prescribed per patient [3.2 versus 2.8] in public hospitals and by general practitioners [GPs] respectively and generic prescribing rates were low [45.2% versus 24.5%]. The rates of prescribing in public hospitals and by GPs were 8.3% versus 23.3% for injections, 68.1% versus 31.9% for antibiotics and 92.6% versus 68.5% for drugs from the essential drugs list. Drug prescribing in both sectors needs to be regulated, especially the use of antibiotics, essential drugs and generic prescribing

EUR_ICP_QCPH_06_03_01.pdf.jpg
Drug pricing and reimbursement : report on a WHO seminar. Hilleroed, Denmark, 3-6 June 1996
World Health Organization. Regional Office for Europe ( 1997 )
Abstract

The seminar focused on the economic aspects of drug supply, including sector management issues and the changing roles and responsibilities of the public sector in a market-oriented supply system. it demonstrated the strong link between health care policies and pharmaceutical sector reform. Participants from all the newly independent states (NIS) of the former USSR concentrated on the issue of reasonably good access, at affordable prices, to essential drugs of good quality. it was agreed that a well functioning pharmaceutical sector depends on a clear division of roles and responsibilities between the public and private sectors. The situation in the NIS presents particular challenges because of systems transition and resource scarcity. Economic principles (incentives to rational use of drugs, cost-containment, supply effciency and alternative financing strategies) play an increasingly important role in making drugs available at affordable cost for patients in these countries. This seminar has strengthened networking among pharmaceutical experts in the NIS

WHO_PHP_73.pdf.jpg
Drug problems in the sociocultural context : a basis for policies and programme planning / edited by Griffith Edwards and Awni Arif
Edwards, Griffith; Arif, Awni; World Health Organization ( 1980 )
Abstract

Investigates the sociocultural context of drug problems in an effort to facilitate the planning of prevention and treatment programmes that are sensitive to the sociocultural setting of drug problems. Following an overview of world drug problems, the book uses numerous case studies from African, American, Asian, and European countries to illustrate sociocultural patterns of drug use, different health care approaches to the treatment and management of drug abusers, and the diversity of strategies that have been used to reduce the demand for drugs. Other chapters cover prevention, policy design, and programme planning viewed from the sociocultural perspective

WHO_EDM_PAR_2004.3_eng.pdf.jpg
Drug promotion : what we know, what we have yet to learn : reviews of materials in the WHO/HAI database on drug promotion / Pauline Norris ... [et al.]
Norris, Pauline; Herxheimer, Andrew; Lexchin, Joel; Mansfield, Peter; World Health Organization. Dept. of Essential Drugs and Medicines Policy; Health Action International ( 2005 )
Drug promotion and education : an uncertain interface
( 1991 )
WPR_RC045_TD2_1994_en.pdf.jpg
Drug quality assurance : technical discussions
( 1994 )
bulletin_1994_72(4)_615-620.pdf.jpg
Drug quality screening in developing countries : establishment of an appropriate laboratory in Swaziland / T. A. Kenyon, A. S. Kenyon & T. Sibiya
Kenyon, T. A; Kenyon, A. S; Sibiya, T ( 1994 )
Showing results 45982 to 46001 of 207649 < previous   next >